These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 22921287)

  • 1. Assessment of the effect of mirodenafil on the hemodynamics of healthy male Korean volunteers administered tamsulosin: a randomized, double-blind, placebo-controlled, 2-period crossover study.
    Gu N; Kim J; Lim KS; Shin KH; Kim TE; Lee B; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2012 Sep; 34(9):1929-39. PubMed ID: 22921287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of alcohol on the hemodynamic effects and pharmacokinetic properties of mirodenafil: a single-dose, randomized-sequence, open-label, crossover study in healthy male volunteers in Korea.
    Kim BH; Yi S; Kim J; Lim KS; Kim KP; Lee B; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Jun; 31(6):1234-43. PubMed ID: 19695390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of udenafil on the hemodynamics of healthy male volunteers administered tamsulosin.
    Kim MG; Kim JR; Kim BH; Lim KS; Shin SG; Jang IJ; Yu KS; Cho JY
    Curr Med Res Opin; 2013 Jun; 29(6):685-93. PubMed ID: 23557068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia.
    Auerbach SM; Gittelman M; Mazzu A; Cihon F; Sundaresan P; White WB
    Urology; 2004 Nov; 64(5):998-1003; discussion 1003-4. PubMed ID: 15533493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC; Fiske K; Lyne A
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic interaction between a daily dosed phosphodiesterase 5 inhibitor, tadalafil, and the alpha-adrenergic blockers, doxazosin and tamsulosin, in middle-aged healthy male subjects.
    Guillaume M; Lonsdale F; Darstein C; Jimenez MC; Mitchell MI
    J Clin Pharmacol; 2007 Oct; 47(10):1303-10. PubMed ID: 17906163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of oral mirodenafil in the treatment of erectile dysfunction in diabetic men in Korea: a multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Park HJ; Choi HK; Ahn TY; Park JK; Chung WS; Lee SW; Kim SW; Hyun JS; Park NC
    J Sex Med; 2010 Aug; 7(8):2842-50. PubMed ID: 20626604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of tamsulosin and sildenafil in separate and combined regimens on detailed hemodynamics in patients with benign prostatic enlargement.
    Nieminen T; Tammela TL; Kööbi T; Kähönen M
    J Urol; 2006 Dec; 176(6 Pt 1):2551-6. PubMed ID: 17085157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of ketoconazole and rifampicin on the pharmacokinetics of mirodenafil in healthy Korean male volunteers: an open-label, one-sequence, three-period, three-treatment crossover study.
    Shin KH; Kim BH; Kim TE; Kim JW; Yi S; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Dec; 31(12):3009-20. PubMed ID: 20110038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic and humoral effects at rest and after head-up tilt tests during 24-hour infusion of a new nitrate ester, ITF 296, compared with ISDN and placebo in healthy volunteers: a double-blind, randomized, within-subject study.
    Sardina M; Warrington SJ; Boyce M; Johnston A; Bianchini C
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S80-90. PubMed ID: 8839231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An oral yohimbine/L-arginine combination (NMI 861) for the treatment of male erectile dysfunction: a pharmacokinetic, pharmacodynamic and interaction study with intravenous nitroglycerine in healthy male subjects.
    Kernohan AF; McIntyre M; Hughes DM; Tam SW; Worcel M; Reid JL
    Br J Clin Pharmacol; 2005 Jan; 59(1):85-93. PubMed ID: 15606445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of the simultaneous administration of mirodenafil and an α-blocker in men with BPH-LUTS: a multicenter open-label prospective study.
    Bang WJ; Oh CY; Yoo C; Cho JS; Yang DY; Lee DH; Lee SH; Chung BH
    Int J Impot Res; 2013; 25(4):149-54. PubMed ID: 23303333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers.
    Houghton LA; Atkinson W; Whorwell PJ; Morris J; Murdoch RD; Cooper SM; Webber DM; Walls CM
    Clin Ther; 2006 Apr; 28(4):569-81. PubMed ID: 16750468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
    García-Morales LM; Berber A; Macias-Lara CC; Lucio-Ortiz C; Del-Rio-Navarro BE; Dorantes-Alvárez LM
    Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the influence of severe renal impairment on the pharmacokinetics of mirodenafil in Korean male volunteers.
    Noh YH; Lim HS; Cho SH; Ghim JL; Choe S; Jung JA; Kim MJ; Kim YH; Jin SJ; Kim SB; Park JS; Lee SK; Yang WS; Chang JW; Lee B; Bae KS
    Int J Clin Pharmacol Ther; 2012 Dec; 50(12):880-8. PubMed ID: 23006442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of once-daily oral fimasartan 20 to 240 mg/d in Korean Patients with hypertension: findings from Two Phase II, randomized, double-blind, placebo-controlled studies.
    Lee H; Yang HM; Lee HY; Kim JJ; Choi DJ; Seung KB; Jeon ES; Ha JW; Rim SJ; Park JB; Shin JH; Oh BH
    Clin Ther; 2012 Jun; 34(6):1273-89. PubMed ID: 22608107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist.
    Webb DJ; Freestone S; Allen MJ; Muirhead GJ
    Am J Cardiol; 1999 Mar; 83(5A):21C-28C. PubMed ID: 10078539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of mirodenafil, a new oral phosphodiesterase type 5 inhibitor, for treatment of erectile dysfunction.
    Paick JS; Ahn TY; Choi HK; Chung WS; Kim JJ; Kim SC; Kim SW; Lee SW; Min KS; Moon KH; Park JK; Park K; Park NC; Suh JK; Yang DY; Jung HG
    J Sex Med; 2008 Nov; 5(11):2672-80. PubMed ID: 18638004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.